ITGAX and neoplasm: Significantly elevated tumor-associated mCherry+ fluorescent signals were observed in CD11c+ DCs from DEXP&A2&N-treated mice compared to DEXP&A2 and PBS controls (Fig. 2b, c), primarily in CD11b−CD11c+ DCs (Additional file 1: Figure S2a and S2b), demonstrating the superior cross-presenting ability of these DCs [25, 26].